Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

73.36 -0.64 (-0.87%)

Streaming Delayed Price Updated: 12:33 PM EDT, Sep 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

ANI Pharmaceuticals: Q2 Earnings Insights ↗

August 08, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q2 earnings results on Monday, August 8, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

August 08, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

August 03, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

July 28, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

July 25, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals: Q1 Earnings Insights ↗

May 10, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Via Benzinga

ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary

July 18, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP

June 22, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Return On Capital Employed Overview ↗

June 08, 2022

According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13...

Via Benzinga

ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition

June 02, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP

June 01, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

May 20, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

May 10, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET ↗

May 06, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results.

Via Benzinga

ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

April 19, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

April 11, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC) ↗

March 28, 2022

Via Benzinga

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

March 22, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals's Return On Capital Employed Insights ↗

March 16, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) brought in sales totaling $60.93 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 442.75%, resulting in...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises Over 200 Points; ANI Pharmaceuticals Shares Slide ↗

March 15, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday. The Dow traded up 1.07% to 33,297.32 while the NASDAQ rose 1.81% to 12,809....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 164.2% to $60.5 during Tuesday's regular session. Incannex Healthcare's stock is trading at a volume of 664.5K...

Via Benzinga

Upbeat Inflation Data, Falling Oil Prices Prop Up Dow ↗

March 15, 2022

Wall Street is eyeing an upbeat session, with the Dow Jones Industrial Average up 377 points at midday.

Via Talk Markets

Mid-Day Market Update: Dow Surges Over 300 Points; Crude Oil Tumbles 8% ↗

March 15, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq gaining more than 200 points on Tuesday. The Dow traded up 1.01% to 33,276.46 while the NASDAQ rose 1.92% to 12,...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Producer Prices Increase 0.8% In February ↗

March 15, 2022

U.S. stocks opened higher this morning, with the Dow Jones surging more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.69% to 33,172.42...

Via Benzinga

ANI Pharma Posts Mixed Bag Q4 Earnings, FY22 Sales Outlook Trails Street Consensus ↗

March 15, 2022

ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q4 revenues were $60.9 million, +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for generic pharmaceutical...

Via Benzinga

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗

March 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

ANI Pharmaceuticals: Q4 Earnings Insights ↗

March 15, 2022

ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:50 AM. Here's what investors need to know about the announcement....

Via Benzinga

ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth

March 15, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.